Compare CVS Health Corp (CVS) vs Gold Fields Limited (GFI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Gold Fields Limited — how do they compare? CVS Health Corp trades at $86.25 (market cap $112.29B), while Gold Fields Limited trades at $37.15 (market cap $31.87B). The key difference: CVS Health Corp is far larger — about 3.5× Gold Fields Limited's market cap, and Gold Fields Limited pays the higher dividend (6%). Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Gold Fields Limited for 49 Days on average.
| CVS | GFI | |
|---|---|---|
Market Cap | $112.29B | $31.87B |
Volume | 7,763,676 | 4,169,651 |
Sector | Health | Basic Materials |
52-Week High | $110.60 | $61.52 |
52-Week Low | $70.08 | $31.25 |
Typical Hold Time | 83 Days | 49 Days |
Enterprise Value | $174.64B | $32.47B |
Dividend Yield | 3.03% | 6% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.95, up 1.76% with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 26% upside. Recent quarterly earnings consistently beat expectations, with Q2 2026 EPS of $2.58 surpassing the $1.85 estimate. Revenue growth remains solid at $402.07 billion for 2025, though net margins compressed to 1.18%. Technical indicators show a bullish overall signal with support at $87 and resistance at $89.
The outlook remains positive given CVS's dominant market position and Medicare expansion plans, but investors face risks from reimbursement pressures and ongoing legal investigations. Earnings growth and successful execution of healthcare services integration represent the primary catalysts for continued stock appreciation.
Gold Fields (GFI) trades at $35.05, down 3.1% amid market reaction to its rejected $27 billion takeover bid for Northern Star. The stock shows strong fundamentals with a P/E of 7.14, robust 38.66% net margin, and record 2025 revenue of $8.75B. Technical indicators are bearish with moving averages signaling sell pressure, though RSI suggests potential oversold conditions. Recent earnings show mixed results with one beat and three misses against expectations.
The outlook remains positive with analyst consensus target of $52.75 (51% upside) and no sell ratings. Key risks include acquisition execution challenges and gold price volatility. The company's strong cash flow generation ($3.77B operating cash flow) and shareholder returns ($1.25B program) support long-term value despite near-term acquisition uncertainty.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Gold Fields Limited
Gold Fields Ltd is a producer of gold and is a holder of gold reserves and resources in South Africa, Ghana, Australia and Peru. In Peru, the company also produces copper. The company is primarily involved in underground and surface gold and surface copper mining and silver and related activities, including exploration, extraction, processing and smelting. It conducts underground and surface mining operations at St. Ives, underground-only operations at Agnew, Granny Smith and South Deep and surface-only open pit mining at Damang, Tarkwa and Cerro Corona. The company's revenues are derived from the sale of gold that it produces.
Read more on GFI →
